0001415889-23-005776.txt : 20230403
0001415889-23-005776.hdr.sgml : 20230403
20230403162319
ACCESSION NUMBER: 0001415889-23-005776
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230331
FILED AS OF DATE: 20230403
DATE AS OF CHANGE: 20230403
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Raykov Rosty
CENTRAL INDEX KEY: 0001468316
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32295
FILM NUMBER: 23792969
MAIL ADDRESS:
STREET 1: C/O ADHEREX TECHNOLOGIES INC.
STREET 2: 4620 CREEKSTONE DRIVE, SUITE 200
CITY: DURHAM
STATE: NC
ZIP: 27703
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: FENNEC PHARMACEUTICALS INC.
CENTRAL INDEX KEY: 0001211583
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A1
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: PO BOX 13628
STREET 2: 68 TW ALEXANDER DRIVE
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
BUSINESS PHONE: (919) 636-4530
MAIL ADDRESS:
STREET 1: PO BOX 13628
STREET 2: 68 TW ALEXANDER DRIVE
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
FORMER COMPANY:
FORMER CONFORMED NAME: FENNEC PHARMACEUTICALS, INC.
DATE OF NAME CHANGE: 20140903
FORMER COMPANY:
FORMER CONFORMED NAME: ADHEREX TECHNOLOGIES INC
DATE OF NAME CHANGE: 20021223
4
1
form4-04032023_080404.xml
X0407
4
2023-03-31
0001211583
FENNEC PHARMACEUTICALS INC.
FENC
0001468316
Raykov Rosty
C/O FENNEC PHARMACEUTICALS, INC.
PO BOX 13628, 68 TW ALEXANDER DRIVE
RESEARCH TRIANGLE PARK
NC
27709
true
true
false
false
CHIEF EXECUTIVE OFFICER
0
Stock Option
8.32
2023-03-31
4
A
0
175000
0
A
2033-03-31
Common shares
175000
1583333
D
Restricted Share Unit
0
2023-03-31
4
A
0
87500
0
A
2033-03-31
Common shares
87500
1670833
D
On March 31, 2023, Rostislav Raykov was granted incentive stock options to purchase 175,000 shares of the issuers common shares pursuant to the issuer's 2020 Equity Incentive Plan.
1/3 of the shares subject to this option shall vest immediately and may be exercised as of March 31, 2024 (the "Vesting Commencement Date"). 1/24 of the shares subject to this option shall vest immediately and may be exercised as of the last day of each month following the Vesting Commencement Date. As of March 31, 2026 and thereafter, 100% of the total number of shares subject to this option shall be vested.
On March 31, 2023, Rostislav Raykov was awarded restricted share units to receive 87,500 shares of the Issuer's common shares pursuant to the Issuer's 2020 Equity Incentive Plan.
1/3 of the shares subject to this award shall be released from restriction as of March 31, 2024 (the "Vesting Commencement Date"). 1/24 of the award shall be released from restriction as of the last day of each month following the Vesting Commencement Date. As of March 31, 2026 and thereafter, 100% of the total number of shares subject to this award shall be released.
/s/ Rostislav Raykov
2023-04-03